Skip to main content

Advertisement

ADVERTISEMENT

News

News
05/28/2021
Ozanimod is now available for the treatment of moderate to severe ulcerative colitis, based on results from the TRUE NORTH trial.
Ozanimod is now available for the treatment of moderate to severe ulcerative colitis, based on results from the TRUE NORTH trial.
Ozanimod is now available for...
05/28/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

News
04/01/2021
Researchers reveal enhanced understanding of monogenic inflammatory bowel disease is essential to improved outcomes.
Researchers reveal enhanced understanding of monogenic inflammatory bowel disease is essential to improved outcomes.
Researchers reveal enhanced...
04/01/2021
Advances in Inflammatory Bowel Disease Network
News
03/22/2021
Researchers report majority of patients practicing food avoidance to avoid relapse are women.
Researchers report majority of patients practicing food avoidance to avoid relapse are women.
Researchers report majority of...
03/22/2021
Advances in Inflammatory Bowel Disease Network
News
03/19/2021
Research finds links between appendectomy and patients with developing bowel diseases.
Research finds links between appendectomy and patients with developing bowel diseases.
Research finds links between...
03/19/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

News
02/26/2021
Humira (adalimumab) proved effective in treating patients aged 5 and older with ulcerative colitis
Humira (adalimumab) proved effective in treating patients aged 5 and older with ulcerative colitis
Humira (adalimumab) proved...
02/26/2021
Advances in Inflammatory Bowel Disease Network
News
01/06/2021
New research has found a novel plasmid associated with ulcerative colitis, but it is unclear if the molecule is a marker of the disease.
New research has found a novel plasmid associated with ulcerative colitis, but it is unclear if the molecule is a marker of the disease.
New research has found a novel...
01/06/2021
Advances in Inflammatory Bowel Disease Network
News
01/04/2021
Best practice statements help to guide decision-making in diagnosis, surveillance, and treatment of ulcerative colitis and Crohn disease among patients aged 60 years and older.
Best practice statements help to guide decision-making in diagnosis, surveillance, and treatment of ulcerative colitis and Crohn disease among patients aged 60 years and older.
Best practice statements help to...
01/04/2021
Advances in Inflammatory Bowel Disease Network

Advertisement

News
12/28/2020
Patients with ulcerative colitis in remission may be more likely to experience moderate to severe levels of fatigue and lack of productivity under certain conditions.
Patients with ulcerative colitis in remission may be more likely to experience moderate to severe levels of fatigue and lack of productivity under certain conditions.
Patients with ulcerative colitis...
12/28/2020
Advances in Inflammatory Bowel Disease Network
News
11/27/2020
Researchers also found that patients with ulcerative colitis who had taken biologic drugs showed no greater rates of complications after colectomy than patients who had not taken these agents.
Researchers also found that patients with ulcerative colitis who had taken biologic drugs showed no greater rates of complications after colectomy than patients who had not taken these agents.
Researchers also found that...
11/27/2020
Advances in Inflammatory Bowel Disease Network
News
11/11/2020
The Bruce and Cynthia Sherman Charitable Foundation will present the 2020 Sherman Prizes and Sherman Emerging Leader Prize to David T. Rubin, MD; Gary D. Wu, MD; and Jessica Allegretti, MD, at the Advances in Inflammatory Bowel Diseases...
The Bruce and Cynthia Sherman Charitable Foundation will present the 2020 Sherman Prizes and Sherman Emerging Leader Prize to David T. Rubin, MD; Gary D. Wu, MD; and Jessica Allegretti, MD, at the Advances in Inflammatory Bowel Diseases...
The Bruce and Cynthia Sherman...
11/11/2020
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement